MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, M. B.
Right arrow Articles by Hakala, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, M. B.
Right arrow Articles by Hakala, M. T.

Relationship of cellular folate cofactor pools to the activity of 5- fluorouracil

MB Yin, SF Zakrzewski and MT Hakala

Volume 23, Issue 1, pp. 190-197, 01/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
V. Cohen, V. Panet-Raymond, N. Sabbaghian, I. Morin, G. Batist, and R. Rozen
Methylenetetrahydrofolate Reductase Polymorphism in Advanced Colorectal Cancer: A Novel Genomic Predictor of Clinical Response to Fluoropyrimidine-based Chemotherapy
Clin. Cancer Res., May 1, 2003; 9(5): 1611 - 1615.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Pectasides, M. Pectasides, D. Farmakis, N. Bountouroglou, M. Nikolaou, M. Koumpou, N. Mylonakis, and C. Kosmas
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
Ann. Onc., April 1, 2003; 14(4): 537 - 542.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Schwartz, T. R. Johnson, A. Goetz, H. Burris, L. Smetzer, T. Lampkin, J. Sailstad, J. A. Hohneker, D. D. Von Hoff, and E. K. Rowinsky
A Phase I and Pharmacokinetic Study of 1843U89, a Noncompetitive Inhibitor of Thymidylate Synthase, in Patients with Advanced Solid Malignancies
Clin. Cancer Res., July 1, 2001; 7(7): 1901 - 1911.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. J.A. Harte, J. C. Matthews, S. M. O'Reilly, D.W. O. Tilsley, S. Osman, G. Brown, S. J. Luthra, F. Brady, T. Jones, and P. M. Price
Tumor, Normal Tissue, and Plasma Pharmacokinetic Studies of Fluorouracil Biomodulation With N-Phosphonacetyl-L-aspartate, Folinic Acid, and Interferon Alfa
J. Clin. Oncol., May 1, 1999; 17(5): 1580 - 1580.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics